Juan Carlos García-Pagán
Publicacions destacades
-
Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors
Autors:Referència: Journal Of Hepatology 2021. -
Coexpression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease
Autors:Referència: Journal Of Hepatology 2021. -
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data
Autors:Referència: Gastroenterology 2021. -
Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis
Autors:Referència: Journal Of Hepatology 2021. -
Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study
Autors:Referència: Hepatology 2020. -
The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery
Autors:Referència: Journal Of Hepatology 2019. -
Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis
Autors:Referència: Faseb Journal 2019. -
Porto-sinusoidal vascular disease: proposal and description of a novel entity
Autors:Referència: Lancet Gastroenterology & Hepatology 2019. -
Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis
Autors:Referència: Liver International 2019. -
Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension.
Autors:Referència: Gastroenterology 2017.
Projectes destacats
-
Estudio prospectivo, multicéntrico y abierto para evaluar la eficacia del esmolol en la identificación precoz de las alteraciones cardiovasculares inducidas por la cirrosis, la diabetes mellitus y los tratamientos cardiotóxicos
Investigador/a principal: Juan Carlos García PagánFinançador: Instituto de Salud Carlos IIICodi: ICI20/00011Durada: 01/11/2020 - 31/10/2023 -
Caracterización de la cirrosis en regresión. Identificación de vías moleculares clave y nuevas estrategias terapéuticas para su potenciación.
Investigador/a principal: Juan Carlos García PagánFinançador: Ministerio de Ciencia, Iinovación y Universidades.Codi: PID2019-105148RB-I00Durada: 01/06/2020 - 31/05/2023 -
A Phase II, Single-arm, Open-Label Study to Characterise the Effect on Portal Pressure, the Effect on Renal Function and the Pharmacokinetic Profile of N-003 in Patients withDecompensated Cirrhosis
Investigador/a principal: Juan Carlos García PagánFinançador: Noorik Biopharmaceuticals AGCodi: HCB/19/611Durada: 30/07/2019 - 31/05/2021 -
Hemodinàmica hepàtica i hipertensió portal. AGAUR_SGR17_00517
Investigador/a principal: Juan Carlos García PagánFinançador: AGAUR ( Agència de Gestió d'Ajuts Universitaris i de la Recerca)Codi: SGR17_00517Durada: 01/01/2017 - 30/09/2021 -
Prognostic factors to identify patients with cirrhosis surviving an acute bleeding episode at high-risk of variceal rebleeding and death during follow-up
Investigador/a principal: Juan Carlos García PagánFinançador: GORE y Asociados S.L.Durada: 01/01/2019 - 31/12/2021